Refractory Hodgkin Lymphoma-Reference-Cited by-同舟云学术

Refractory Hodgkin Lymphoma

Published:2013-09 Issue:5 Volume:25 Page:463-469
ISSN:1040-8746
Container-title:Current Opinion in Oncology
language:en
Short-container-title:

Author:

von Tresckow Bastian,Engert Andreas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference25 articles.

1. Prolonged disease-free survival in Hodgkins disease with MOPP reinduction after first relapse.;Fisher;Ann Intern Med,1979

2. New prognostic score based on treatment outcome of patients with relapsed Hodgkins lymphoma registered in the database of the German Hodgkins lymphoma study group.;Josting;J Clin Oncol,2002

3. A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model.;Moskowitz;Blood,2001

4. Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkins lymphoma autografted after a first relapse.;Sureda;Ann Oncol,2005

5. Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin Lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG).;Josting;Ann Oncol,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Cox2, CD163, and Microvessel Density Expression on the Prediction of Relapse and Patients? Outcome in Classical Hodgkin Lymphoma;MIDDLE EAST J CANCER;2022

2. Utility of Routine Surveillance Imaging for Hodgkin Disease following Autologous Transplant: Experiences from a Single Institution;Acta Haematologica;2018

3. Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma;Hematological Oncology;2016-04-06

4. Low-dose pembrolizumab induced remission in patients with refractory classical Hodgkin lymphoma;British Journal of Haematology;2016-01-15

5. Systematic review and meta-analysis on the prognostic value of complete remission status at FDG-PET in Hodgkin lymphoma after completion of first-line therapy;Annals of Hematology;2015-10-20